Harmful Drugs Law
There are four questions that should be considered when considering a COX-2 inhibitor NSAID:
1. Is the COX-2 inhibitor agent selective? (An agent must be more than 100-fold more COX-2 selective than COX-1 to meet this criteria.)
2. Does the COX-2 inhibitor agent have a sparing effect for stomach ulcers and other gastrointestinal bleeding and complications?
3. Does the COX-2 inhibitor agent spare platelet function? (This is particularly important for those at risk for heat attacks, strokes or other cardiovascular condition caused by blood clots.)
4. Is the COX-2 inhibitor agent effective clinically?